AlzeCure Pharma
Phase 2AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders.
Founded
2011
Focus
Small Molecules
About
AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders.
Funding History
3Total raised: $32.5M
IPO$15MUndisclosedJun 30, 2021
Series B$12MFlerie InvestSep 15, 2020
Series A$5.5MKreos CapitalJun 15, 2018
Company Info
TypePrivate
Founded2011
LocationStockholm, Sweden
StagePhase 2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile